（编辑 任世碧） 证券日报网讯 9月18日晚间，东软集团发布公告称，公司近日收到国内某知名大型汽车厂商（限于保密 条款，无法披露其具体名称，简称"汽车厂商"）的定点通知，选择东软作为其指定供应商，为其供应智 能座舱域控制器。根据该汽车厂商的规划，上述产品将应用于其搭载高通8397平台的多款车型，预计自 2026年第四季度起陆续量产上市，预计生命周期约为4年；在上述车型生命周期内，预计公司将为其供 应智能座舱域控制器涉及总金额在56亿元人民币左右。 ...

2024年，公司凭借高通8295座舱全球首个量产供货以及在银河E8等车型连续落地的领先优势，位居"高 阶智能座舱域控平台中国本土供应商竞争力"榜单第一名。 东软集团表示，公司本次基于高通8397平台打造的端侧AI智能座舱域控制器，实现了AI大模型本地部 署，并将充分融合AI算力与端侧多模态大模型技术，具备全场景感知与推理能力，通过语音、视觉、 触觉等多模态识别用户需求并主动提供精准服务，兼顾响应速度、隐私保护与服务丰富性。 据了解，东软集团与该汽车厂商保持着长期良好的合作关系，东软的智能座舱、智能通信等系列产品已 成功应用于该汽车厂商的多款主流车型。本次项目定点，是双方长期合作的进一步深化，也是汽车厂商 对东软汽车智能化核心产品与技术综合实力的持续认可，有利于进一步巩固公司领先优势，持续提升公 司核心竞争力与市场份额。公司同时提示，定点通知并不反映车厂最终的实际采购数量，目前仅为预计 金额，后续实际开展情况存在不确定性。 东软集团（600718）9月18日公告，公司近日收到国内某知名大型汽车厂商（限于保密条款，无法披露 其具体名称）的定点通知，选择东软作为其指定供应商，为其供应智能座舱域控制器。 根据该汽车厂 ...

Mergers and Acquisitions - Anhui Heli plans to acquire 51% stake in Jianghuai Heavy Industry [1] Share Buybacks and Equity Transfers - Gansu Guotou will receive 90% stake in Lanshi Group for free, becoming the indirect controlling shareholder [2] - Jian Sheng Group intends to repurchase shares worth between 150 million to 300 million RMB, with a maximum repurchase price of 14.69 RMB per share [3] - Goodway adjusts the maximum repurchase price from 53 RMB per share to 70 RMB per share [4] - Shareholder Lu Tichao plans to transfer 1.7 million shares, accounting for 2.0038% of the total share capital [5] - Zhengqiang shares' controlling shareholder will transfer 8.9% of shares [6] - Heyuan Gas plans to repurchase and cancel 45,000 restricted shares [7] External Investments and Daily Operations - Neusoft Group received a notification for a project involving a total amount of approximately 5.6 billion RMB for supplying intelligent cockpit domain controllers [8] - Fulian Precision's subsidiary received a 1.5 billion RMB advance payment from CATL to secure the supply of lithium iron phosphate [9] - Jian Sheng Group plans to invest 180 million RMB in a project to produce 60 million pairs of mid-to-high-end cotton socks and 30 million pieces of clothing in Vietnam [10] - Fengshan Group signed a technology development contract with Tsinghua University for the development of sodium-ion battery electrolytes and solid-state lithium-ion battery electrolytes [11] - Palm Holdings won a bid for a high-standard farmland construction project worth 433 million RMB [12] - Heng Rui Medicine's subsidiary received clinical trial approval for SHR-1139 injection [11] - Huaxiang plans to issue convertible bonds to raise no more than 1.308 billion RMB for core component capacity enhancement and industrial chain extension projects [12] - Shentong Express reported August express service revenue of 4.434 billion RMB, a year-on-year increase of 14.47%, with a business volume of 2.147 billion tickets, up 10.92% year-on-year [12] - YTO Express reported August express product revenue of 5.39 billion RMB, a year-on-year increase of 9.82%, with a business volume of 2.511 billion tickets, up 11.08% year-on-year [12]

一、定点通知概况 公司近日收到国内某知名大型汽车厂商（限于保密条款，无法披露其具体名 称，以下简称"汽车厂商"）的定点通知，选择东软作为其指定供应商，为其供 应智能座舱域控制器。根据该汽车厂商的规划，上述产品将应用于其搭载高通 8397 平台的多款车型，预计自 2026 年第四季度起陆续量产上市，预计生命周期 约为 4 年；在上述车型生命周期内，预计公司将为其供应智能座舱域控制器涉及 总金额在 56 亿元人民币左右。 证券代码：600718 证券简称：东软集团 公告编号：临 2025-061 东软集团股份有限公司 关于收到汽车厂商定点通知的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 定点通知并不反映车厂最终的实际采购数量，目前仅为预计金额，后续 实际开展情况存在不确定性。 公司实际销售金额将与汽车实际产量等因素直接相关，而汽车市场整体 情况等因素均可能对车厂的生产计划和采购需求构成影响，进而为供货 量带来不确定性影响。 2、公司实际销售金额将与汽车实际产量等因素直接相关，而汽车市场整体 情况等因素均可 ...

格隆汇9月18日丨东软集团(600718.SH)公布，公司近日收到国内某知名大型汽车厂商(限于保密条款， 无法披露其具体名称，以下简称"汽车厂商")的定点通知，选择东软作为其指定供应商，为其供应智能 座舱域控制器。根据该汽车厂商的规划，上述产品将应用于其搭载高通8397平台的多款车型，预计自 2026年第四季度起陆续量产上市，预计生命周期约为4年;在上述车型生命周期内，预计公司将为其供应 智能座舱域控制器涉及总金额在56亿元人民币左右。 ...

证券之星消息，根据天眼查APP-财产线索数据整理，根据云南大学附属医院月9日15发布的 《4530000JH202515703：云南大学附属医院智慧医保服务平台信息系统合同公告》内容显示，东软集 团股份有限公司中标，详情如下： 标题：4530000JH202515703：云南大学附属医院智慧医保服务平台信息系统合同公告 通过天眼查大数据分析，东软集团股份有限公司共对外投资了102家企业，参与招投标项目43280次；财 产线索方面有商标信息428条，专利信息2251条，著作权信息2677条；此外企业还拥有行政许可68个。 数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 采购方：云南大学附属医院 供应商：东软集团股份有限公司 中标金额：1100000.0 地区：云南省 发布日期：2025-09-15 ...

东软集团股份有限公司 2025 年第二次临时股东大会文件目录 东软集团股份有限公司 2025 年第二次临时股东大会文件目录 | 2025 年第二次临时股东大会议程 1 | | --- | | 关于取消监事会并修改《公司章程》的议案 2 | | 关于修订《股东会议事规则》的议案 77 | | 关于修订《董事会议事规则》的议案 85 | | 关于修订《独立董事工作制度》的议案 91 | | 关于制定《董事、高级管理人员薪酬管理制度》的议案 98 | | 关于修订《募集资金管理制度》的议案 102 | | 关于制定《对外担保管理制度》的议案 110 | | 关于制定《防范控股股东、实际控制人及其他关联方资金占用管理制度》的议案 114 | 东软集团股份有限公司 2025 年第二次临时股东大会议程 东软集团股份有限公司 2025 年第二次临时股东大会议程 时间：2025 年 9 月 24 日 上午 10 时 地点：沈阳市浑南新区新秀街 2 号 东软软件园 会议中心 参加人员：股东及股东授权代表、董事会成员、监事会成员、高级管理人员、 见证律师等 主持人：荣新节 会议议案： 1. 关于取消监事会并修改《公司章程》的议案 ...

Group 1: Company Overview - Neusoft has over 30 years of experience in the healthcare sector, being the leading provider of digital health solutions in China with the highest market share [3] - The company has developed a comprehensive industrial ecosystem covering medical insurance, smart healthcare, big data and AI in healthcare, medical equipment manufacturing, cloud hospitals, and health education [3] - Neusoft is the manufacturer of China's first CT scanner, with over 14,000 hospitals in more than 110 countries using its medical equipment, totaling over 50,000 installations [3] Group 2: Innovations and Solutions - Neusoft launched China's first photon-counting CT in August 2025, which is also the world's first 8cm wide photon-counting CT, marking a significant breakthrough in China's high-end medical equipment industry [3] - The integration of digital technology and healthcare is becoming a core driver of industry transformation, with data value realization in areas like elderly care and employment being crucial for high-quality national development [5] - Neusoft has introduced the "Tianyi" intelligent solution in the healthcare sector, successfully implemented in multiple hospitals, focusing on data value extraction from social security, medical insurance, and healthcare data [5] Group 3: Future Challenges and Goals - The core challenge for the healthcare system in the next five years is achieving more precise and balanced allocation of medical resources [6] - Neusoft aims to leverage AI and big data to enhance hospital operations, disease diagnosis, treatment, and health management, thereby addressing resource imbalance [6] - The company seeks to collaborate with partners globally to promote the digital and intelligent development of the healthcare industry, aiming to provide high-quality and efficient medical services [6]

Core Insights - Data is recognized as the fifth production factor, characterized by non-competition, replicability, and unlimited growth potential, making its value extraction process more complex than traditional production factors [1] - The development of the data factor market relies heavily on a clear policy framework and implementation pathways, with local data trading institutions and data merchants emerging as key drivers [1] - The establishment of a robust ecosystem for data supply and usage is essential to achieve the goals of effective data flow and security [1] Group 1: Industry Overview - The data factor market is currently in a critical phase driven by policies and practical explorations, with the establishment of the National Data Bureau marking a significant step towards a unified national data market [19][20] - The market is projected to exceed 200 billion by 2025, with a compound annual growth rate of over 25% [23] - The construction of a complete national data circulation system is planned over the next five years, aiming to empower the real economy and break data monopolies [27] Group 2: Service Providers and Evaluation - The "iResearch - Top 30 Data Factor Service Providers" list includes companies recognized for their comprehensive capabilities in the data factor industry [7][9] - The evaluation model for service providers includes four core dimensions: industry depth, product and technology capabilities, service capabilities, and ecosystem capabilities [4] - The selection process involved consultations with industry experts and was based on a thorough assessment of the companies' current capabilities [2][3] Group 3: Case Studies and Applications - Neusoft's City Data Value Empowerment Platform focuses on key areas such as smart healthcare and employment, creating a comprehensive service ecosystem [11][12] - The platform aims to enhance urban digital transformation and improve governance through data integration and intelligent services [12] - The "Fujian Public Service Operation Platform" exemplifies a model that integrates service, regulation, and operation across various sectors [15] Group 4: Challenges and Future Directions - The industry faces challenges such as an incomplete pricing system and compliance barriers that hinder data circulation [31][28] - A dual approach involving standardization and case studies is proposed to address these challenges and facilitate the deep release of data value [31][29] - The focus on high-quality data sets and specialized intelligent entities is expected to become mainstream, with ecosystem building and scenario construction as core competitive advantages [20][21]

Market Overview - The Shanghai Composite Index closed at 3819.32 points, with a gain of 0.32%, and the total trading volume of A-shares reached 1,641.14 billion yuan [1] - As of the current date, 29 A-shares have surpassed their annual moving average, indicating positive market sentiment [1] Notable Stocks - The stocks with the highest deviation rates from their annual moving average include: - Luopuskin (002333) with a deviation rate of 8.13% and a daily increase of 9.94% [1] - ST Huaxi (002630) with a deviation rate of 4.11% and a daily increase of 4.88% [1] - Wutong Holdings (300292) with a deviation rate of 3.67% and a daily increase of 5.35% [1] - Other stocks that have just crossed their annual moving average with lower deviation rates include: - Jiecheng Co. (300182) with a deviation rate of 0.04% and a daily increase of 1.60% [2] - Ganyue Expressway (600269) with a deviation rate of 0.05% and a daily increase of 0.40% [2] - Guangsha Huaneng (873703) with a deviation rate of 0.06% and a daily increase of 0.96% [2] Trading Activity - The trading turnover rate for notable stocks shows significant activity, with Luopuskin (002333) having a turnover rate of 3.79% and ST Huaxi (002630) at 6.77% [1] - The overall trading environment reflects a mix of high and low turnover rates among stocks that have recently crossed their annual moving averages [1][2]